Target intelligence / Profile preview

Cysteine and glycine-rich protein 3 (cardiac LIM protein) (CSRP3)

Target
CSRP3
Molecular classification
LIM domain protein, Scaffold/adaptor protein, Structural constituent of muscle, Other
01

Overview

Cysteine and glycine-rich protein 3 (CSRP3), also referred to as cardiac LIM protein or muscle LIM protein, is a small structural protein (194 amino acids) encoded by the CSRP3 gene, predominantly expressed in cardiac and skeletal muscle. CSRP3 contains two LIM domains which mediate extensive protein–protein interactions with cytoskeletal, costameric, and nuclear factors, orchestrating sarcomeric organization, mechanical stretch sensing, and muscle differentiation. Mutations or altered expression of CSRP3 are directly linked to dilated and hypertrophic cardiomyopathy, as well as heart failure and various skeletal myopathies. CSRP3 serves as a scaffold essential for Z-disc integrity, actin filament stability, and mechanotransduction within myocytes, and also acts as a cofactor for transcription factors regulating myogenesis. Diagnostic and biomarker applications include detection of mutations or abnormal protein levels in cardiomyopathic tissues; however, direct pharmacological targeting and approved drugs for CSRP3 are currently absent

Other names
cardiac LIM proteinmuscle LIM proteinMLPCRP3CLPCMD1MCMH12LIM domain proteinLIM domain only 4cysteine-rich protein 3
02

Biological functions

Mechanical stretch sensor (Z-disc complex)Positive regulator of myogenesis (muscle differentiation)Scaffold for sarcomeric macromolecular complexesCytoskeleton remodeling (actin filament cross-linking, depolymerization modulation)Transcriptional cofactor (for myogenic transcription factors)Regulation of calcium sensitivity and contractilityRegulation of energy metabolismCalcineurin anchorage and stress signalingMaintenance of muscle cell integrity
03

Disease associations

Cardiovascular disease (dilated cardiomyopathy, hypertrophic cardiomyopathy)Muscle diseases/myopathies (e.g., facioscapulohumeral muscular dystrophy, nemaline myopathy, limb girdle muscular dystrophy)Heart failure
04

Safety considerations

Loss-of-function or pathogenic mutations lead to severe muscle and cardiac dysfunctionChallenges in targeting protein-protein interactions and regulatory domains
05

Biomarkers

CSRP3 expression levels (biomarker for heart failure, cardiomyopathies, some skeletal myopathies)CSRP3 mutations (W4R, C58G, K69L, etc., as genetic markers in inherited cardiomyopathies)

Beyond the preview

Go deeper on Cysteine and glycine-rich protein 3 (cardiac LIM protein) (CSRP3).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Cysteine and glycine-rich protein 3 (cardiac LIM protein) (CSRP3).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call